Canadian diabetes association national nutrition committee technical review: Advanced glycation end-products in diabetes management

Canadian Journal of Diabetes

Volumn 34, Issue 2, 2010, Pages 136-140

  Hsu, Doreen ^a   Zimmer, Victoria ^b  

^a BRESCIA UNIVERSITY COLLEGE   (Canada)

^b RYERSON UNIVERSITY   (Canada)

Author keywords

Advanced glycation end products; Diabetes complications

Indexed keywords

ADVANCED GLYCATION END PRODUCT;

BLOOD LEVEL; CANADA; CARDIOVASCULAR DISEASE; CELL DAMAGE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE SEVERITY; FOOD COMPOSITION; FOOD INTAKE; GLYCEMIC CONTROL; HUMAN; INFLAMMATION; ORGAN INJURY; REVIEW; TISSUE INJURY; WOUND HEALING IMPAIRMENT;

EID: 77955689330     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-2671(10)42010-9     Document Type: Review

References (24)

1. Public Health Agency of Canada. The face of diabetes. 2008. Available at: http://www.phac-aspc.gc.ca/cd-mc/diabetesdiabete/face-eng.php. Accessed May 15, 2010.
2. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus. N Engl J Med. 1993;329:977-986
3. Ono Y, Aoki S, Ohnishi K, et al. Increased serum levels of advanced glycation end-products and diabetic complication. Diabetes Res Clin Pract. 1998;41:131-137
4. Peppa M, Uribarri J, Vlassara H. Glucose, advanced glycation end products, and diabetes complications: what is new and what works. Clin Diabetes. 2003;21:186-187
5. Ames JM. Evidence against dietary glycation end products being a risk to human health. Mol Nutr Food Res. 2007;51:1085-1090.
6. Henle T. Dietary advanced glycation end products a risk to human health? A call for an interdisciplinary debate. Mol Nutr Food Res. 2007;51:1075-1080
7. Goldin A, Beckman JA, Schmidt AM, et al. Advanced glycation end products: sparking the development of diabetic vascular injury. J Am Heart Assoc. 2006;114:597-605
8. Uribarri J, Cai W, Sandu O, et al. Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects. Ann N Y Acad Sci. 2005;1043:461-466
9. Yan SF, Ramasamy R, Schmidt AM. Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications. Nature Clin Pract Endocrinol Metab. 2008;4:285-293
10. Kisch ES, Ayalon D. Advanced glycosylated end products derived from external sources contribute to diabetic complications. Pract Diabetes Int. 2003;7:259-261
11. Ahmed N. Advanced glycation endproducts role in pathology of diabetic complications. Diabetes Res Clin Pract. 2005;67:3-21
12. Huebschmann AG, Regensteiner JG, Vlassara H, et al. Diabetes and advanced glycoxidation end products. Diabetes Care. 2006;29:1420-1432
13. Uribarri J, Cai WJ, Peppa M, et al. Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J Gerontol A Biol Sci Med Sci. 2007;62:427-433
14. Vlassara H, Palace MR. Diabetes and advanced glycation end products. J Intern Med. 2002;251:87-101
15. Koschinsky T, He CJ, Mitsuhashi T, et al. Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci. 1997;94:6474-6479
16. Kikuchi A, Shinpo K, Takeuchi M, et al. Glycation a sweet tempter for neuronal death. Brain Res Rev. 2003;41:306-323
17. Hammes HP, Alt A, Niwa T et al. Differential accumulation of advanced glycation end products in the course of diabetic retinopathy. Diabetologia. 1999;42:728-736
18. Basta G, Schmidt AM, De Caterina R. Advance glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res. 2004;63:582-592
19. Uribarri J, Peppa M, Cai W, et al. Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients. J Am Soc Nephrol. 2003;14:728-731
20. Jandeleit-Dahm KA, Lassila M, Allen TJ. Advanced glycation end products in diabetes-associated atherosclerosis and renal disease. Ann N Y Acad Sci. 2005;1043:759-766
21. Vlassara H, Fuh H, Makita Z, et al. Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Proc Natl Acad Sci USA. 1992;89:12043-12047
22. Goldberg Y, Cai WJ, Peppa M, et al. Advanced glycation end products in commonly consumed foods. J Am Diet Assoc. 2004;14:1287-1291
23. Health Canada. Eating Well with Canada's Food Guide. Ottawa, ON: Health Products and Food Branch, Office of Nutrition and Promotion; 2007. Publication H39-166/1990E. Available at: http://www.canadasfoodguide.org. Accessed May 15, 2010.
24. Johansen MB, Keimer L, Brunak S. Analysis and prediction of mammalian protein glycation. Glycobiology. 2006;16:844-853.